ERα drives most #breastcancers — but context matters 🧫 Cofactor partnerships and genomic binding differences may explain why ovarian & uterine #cancers respond differently to therapy 👩🏾‍🔬 #InternationalWomensDay
https://ow.ly/sF5M50Yh1jm

Detecting early-stage cancers with a liquid biopsy measuring epigenetic instability – BioNews Central A novel liquid biopsy method using a new metric, the Epigenetic Instability Index, accurately distinguishes patients with early-stage lung and breast cancers from healthy individuals. ...

A novel #LiquidBiopsy method using a new metric, the #EpigeneticInstability Index, accurately distinguishes patients with early-stage lung and #BreastCancers from healthy individuals.
#EarlyDetection #LungCancer

Radiation therapy for lobular breast cancer: opportunities and challenges for leveraging radiosensitivity - PubMed Invasive lobular carcinoma (ILC) is the most common special histological subtype of breast cancer, accounting for 15% of cases. ILC has unique clinical and molecular characteristics yet is treated largely agnostic of subtype. We explore challenges and opportunities in treating ILC, focusing on the u …

Always happy 2C more focused research on #lobular #breastcancer! TY @mjsikora.bsky.social 🙏

Conclusion: #ILC presents unique clinical challenges among #breastcancers, from its subtle manifestation making early detection difficult, 2 resistance 2 convent'al txs like chemo & ..." 1/2 #CanSky #Bcsm

The FAST MRI DYAMOND breast cancer screening study – How did we get here? | North Bristol NHS Trust A new study is investigating whether FAST MRI, a new type of scan, can help detect small but aggressive breast cancers earlier. Now open to patients, the

“I was so excited to read #FASTMRI found #breastcancers smaller and earlier than mammograms. I wanted to bring it to
Bristol”

9 years on Lyn Jones, the DYAMOND study lead, shares what it has taken to open the trial to patients.

👉 bit.ly/3KkSO1s

Breast cancer clues hint at response to therapy in animal models The findings bring us one step closer to improving ER+ breast cancer patients’ response to therapy.

Some #breastCancers provide clues indicating whether they are susceptible to #therapy, helping inform treatment decisions. E Chang et al. #ScienceTM @bcmhouston.bsky.social #BCMCancerCenter blogs.bcm.edu/2025/09/18/f...

Bee venom could help treat a type of cancer Breast cancer is the most common cancer in women in the U.S., with the exception of skin cancers, according to the American Cancer Society.

#Research is indicating that #BeeVenom can help treat #BreastCancers:

www.newsweek.com/bee-venom-co...

www.researchgate.net/search?q=bee...

In the adjuvant setting, vaccines against melanoma and pancreatic cancer appear to be reducing minimal residual disease and relapse. In the #macrometastatic setting, in-situ vaccines have induced systemic regressions in advanced-stage #lungcancers & #breastcancers & #lymphomas

Through #ICARE, we are conducting free #genomic testing on #breast #tumor samples to better understand inherited #breastcancers. Enroll in ICARE using the link below and we will assess your eligibility for this and other focused research efforts
redcap.link/ICAREconsent

“Triple negative breast cancers have the highest rate of recurrence within the first 5 years from diagnosis,” said Cheung, who will partner with Fred Hutch epidemiologist Dr. Kathi Malone on the research project. Triple negative #breastcancers also lack common therapy targets, hence their name. 2/5

External Validation of a Commercial Artificial Intelligence Algorithm on a Diverse Population for Detection of False Negative Breast Cancers AbstractObjective. There are limited data on the application of artificial intelligence (AI) on nonenriched, real-world screening mammograms. This work aim

#ArtificialIntelligence detected 54% of false negative #BreastCancers in a recent Journal of Breast Imaging study. Read the conclusions from UCLA Radiology researchers. doi.org/10.1093/jbi/...

Roswell Park-Led Team Proposes CDK2 Enzyme as New Target for Cancer Therapy A new study published in the journal Nature Communications, led by Agnieszka Witkiewicz, MD, and Erik Knudsen, PhD, of Roswell Park, highlights the therapeutic impact of CDK2 inhibitors as treatment f...

New research from our team highlights a potential new treatment approach for some #breastcancers.

By targeting the enzyme #CDK2, scientists hope to overcome resistance to common treatments for cancers including breast and #pancreaticcancer.

Learn more: www.roswellpark.org/newsroom/202...

Also ... it's not always a lump! Look for changes in your breast! Mammograms aren't perfect & often miss #breastcancer in #densebreasts.

Also, #lobularBC - which is about 15% of all #breastcancers - does not make lumps & is easily missed on mamms. #KnowYourDensity #KnowYourCancers #CanSky #MedSky

I don't know if #lobular is "scarier" than other #breastcancers, but it's definitely been understudied and underfunded, research-wise, over the years. That's why a bunch of #lobmobbers got together and created the @lobularbca.bsky.social. 😘 #knowledgeispower #FUcancer
#CanSky #MedSky #CancerBS

Through #ICARE, we are conducting free #genomic testing on #breast #tumor samples to better understand inherited #breastcancers. Enroll in ICARE using the link below and we will assess your eligibility for this and other focused research efforts

redcap.link/ICAREconsent

@tpalmd.bsky.social

High-risk ER+ Breast Cancers Genomically Resemble HER2+ Tumors Main Finding: HER2+ breast tumors and high-risk ER+ breast tumors share genomic features that reflect similar mechanisms of tumor evolution.Concept: The genomic architecture of breast cancer is constr...

Cancer Discovery #ResearchWatch: High-risk ER+ #BreastCancers Genomically Resemble HER2+ Tumors, a summary of the study by @khoulahan.bsky.social, @lisemangiante.bsky.social, @crissotomayor.bsky.social, @alvinahere.bsky.social, @cncurtis.bsky.social + colleagues @ Stanford

doi.org/10.1158/2159...